RIGL | | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Officer | Feb 05, 2024 | Sale | $1.14 | 8,918 | 10,167 | 349,093 | Feb 06, 2024, 08:18 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Officer | Feb 02, 2024 | Sale | $1.13 | 5,601 | 6,329 | 358,011 | Feb 06, 2024, 08:18 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | Feb 02, 2024 | Sale | $1.13 | 5,601 | 6,327 | 409,918 | Feb 06, 2024, 08:18 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | Feb 05, 2024 | Sale | $1.14 | 7,027 | 8,011 | 402,891 | Feb 06, 2024, 08:18 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | Feb 02, 2024 | Sale | $1.13 | 22,349 | 25,261 | 2,067,174 | Feb 06, 2024, 08:18 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | Feb 05, 2024 | Sale | $1.14 | 30,545 | 34,821 | 2,036,629 | Feb 06, 2024, 08:18 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | Feb 06, 2023 | Sale | $1.75 | 20,340 | 35,595 | 1,680,713 | Feb 07, 2023, 04:30 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Santos David A | EVP, Chief Commercial Officer | Feb 02, 2023 | Sale | $1.66 | 5,388 | 8,945 | 144,612 | Feb 06, 2023, 05:41 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP & Chief Financial Officer | Feb 02, 2023 | Sale | $1.66 | 5,389 | 8,946 | 196,519 | Feb 06, 2023, 05:40 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Dummer Wolfgang | EVP & CMO | Feb 02, 2023 | Sale | $1.66 | 5,389 | 8,946 | 72,459 | Feb 06, 2023, 05:40 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | Jun 09, 2022 | Buy | $0.69 | 1,000,000 | 688,400 | 1,391,776 | Jun 13, 2022, 04:36 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Schorno Dean L | EVP &Chief Financial Officer | May 22, 2019 | Buy | $2.13 | 50,000 | 106,544 | 50,000 | May 23, 2019, 08:21 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Cabatuan Nelson | Principal Accounting Officer | Oct 12, 2018 | Sale | $3.12 | 10,000 | 31,200 | 58 | Oct 16, 2018, 06:46 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Duliege Anne-Marie | EVP & Chief Medical Officer | Sep 17, 2018 | Option Exercise | $2.97 | 306,000 | 907,995 | 115,500 | Sep 19, 2018, 06:26 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Mayer Eldon C. III | EVP & Chief Commercial Officer | Sep 10, 2018 | Buy | $3.28 | 50,000 | 164,210 | 165,000 | Sep 12, 2018, 12:00 AM |
RIGL | | RIGEL PHARMACEUTICALS INC | Mayer Eldon C. III | EVP & Chief Commercial Officer | Sep 11, 2018 | Buy | $3.23 | 50,000 | 161,340 | 215,000 | Sep 12, 2018, 12:00 AM |
RIGL | | RIGEL PHARMACEUTICALS INC | Duliege Anne-Marie | EVP & Chief Medical Officer | Sep 04, 2018 | Option Exercise | $3.02 | 33,000 | 99,771 | 16,500 | Sep 06, 2018, 07:02 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Mayer Eldon C. III | EVP & Chief Commercial Officer | Aug 23, 2018 | Buy | $2.82 | 100,000 | 282,320 | 115,000 | Aug 27, 2018, 07:49 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, President | Aug 17, 2018 | Buy | $2.63 | 114,000 | 300,002 | 173,519 | Aug 21, 2018, 07:12 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Duliege Anne-Marie | EVP & Chief Medical Officer | Jul 02, 2018 | Sale | $2.79 | 5,000 | 13,932 | 0 | Jul 05, 2018, 06:59 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Duliege Anne-Marie | EVP & Chief Medical Officer | Apr 20, 2018 | Sale | $4.11 | 5,000 | 20,550 | 0 | Apr 24, 2018, 09:06 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Maynard Ryan D | EVP & CFO | Nov 03, 2017 | Sale | $3.02 | 200,000 | 604,000 | 100,000 | Nov 07, 2017, 09:07 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Duliege Anne-Marie | Chief Medical Officer | Jul 05, 2017 | Sale | $2.69 | 5,000 | 13,427 | 0 | Jul 07, 2017, 05:39 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Duliege Anne-Marie | Chief Medical Officer | Jan 03, 2017 | Sale | $2.41 | 5,000 | 12,027 | 0 | Jan 13, 2017, 06:02 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | PAYAN DONALD G | EVP, Pres. Discovery&Research | Aug 30, 2016 | Sale | $4.00 | 5,303 | 21,214 | 53,031 | Sep 01, 2016, 06:18 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | PAYAN DONALD G | EVP, Pres. Discovery&Research | Jun 10, 2015 | Sale | $2.91 | 83,332 | 242,379 | 100,000 | Jun 12, 2015, 07:22 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | PAYAN DONALD G | EVP, Pres. Discovery&Research | Apr 01, 2015 | Sale | $3.75 | 10,000 | 37,518 | 58,334 | Apr 03, 2015, 08:35 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | VANCE DOLLY | EVP Corp. Affairs, G.C., Sect. | Dec 18, 2014 | Sale | $2.22 | 1,000 | 2,220 | 575 | Dec 22, 2014, 06:26 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | VANCE DOLLY | EVP Corp. Affairs, G.C., Sect. | Dec 18, 2014 | Sale | $2.22 | 1,000 | 2,220 | 575 | Dec 19, 2014, 06:56 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | PAYAN DONALD G | EVP, Pres. Discovery&Research | Sep 03, 2014 | Sale | $2.56 | 20,000 | 51,200 | 68,334 | Sep 05, 2014, 06:07 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | PAYAN DONALD G | EVP, Pres. Discovery&Research | Feb 24, 2014 | Sale | $3.71 | 20,000 | 74,238 | 88,334 | Feb 26, 2014, 07:21 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | BVF INVESTMENTS LLC | See Explanation of Responses | Nov 19, 2013 | Sale | $2.64 | 484,622 | 1,280,274 | 1,123,848 | Nov 20, 2013, 02:13 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | BIOTECHNOLOGY VALUE FUND II LP | See Explanation of Responses | Jun 07, 2013 | Buy | $3.47 | 32,700 | 113,394 | 1,455,414 | Jun 11, 2013, 05:55 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Maynard Ryan D | EVP & CFO | Sep 12, 2012 | Sale | $8.58 | 46,604 | 399,790 | 23,302 | Sep 14, 2012, 07:57 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | VANCE DOLLY | EVP Corp. Affairs, G.C., Sect. | Sep 13, 2012 | Sale | $10.43 | 4,151 | 43,284 | 1,103 | Sep 14, 2012, 06:45 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Maynard Ryan D | EVP & CFO | Sep 07, 2012 | Option Exercise | $8.58 | 46,604 | 399,790 | 23,302 | Sep 14, 2012, 06:19 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Maynard Ryan D | EVP & CFO | Sep 07, 2012 | Option Exercise | $8.52 | 68,224 | 581,347 | 34,112 | Sep 11, 2012, 06:07 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Maynard Ryan D | EVP & CFO | Sep 10, 2012 | Option Exercise | $8.50 | 35,172 | 299,060 | 17,586 | Sep 11, 2012, 06:07 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Maynard Ryan D | EVP & CFO | Aug 07, 2012 | Sale | $8.55 | 3,400 | 29,073 | 1,700 | Aug 09, 2012, 05:39 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | PAYAN DONALD G | EVP, Pres. Discovery&Research | Jun 19, 2012 | Sale | $8.70 | 10,000 | 87,008 | 118,234 | Jun 20, 2012, 05:45 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Deerfield Special Situations Fund International LTD | 10% Owner | May 26, 2011 | Buy | $8.00 | 301,424 | 2,411,392 | 3,204,167 | Jun 07, 2011, 05:27 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Deerfield Special Situations Fund International LTD | 10% Owner | May 26, 2011 | Buy | $8.00 | 229,252 | 1,834,016 | 2,279,997 | Jun 07, 2011, 05:27 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | DEERFIELD INTERNATIONAL LTD | 10% Owner | May 26, 2011 | Buy | $8.00 | 72,800 | 582,400 | 762,700 | Jun 07, 2011, 05:27 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Deerfield Special Situations Fund, L.P. | 10% Owner | May 26, 2011 | Buy | $8.00 | 46,524 | 372,192 | 470,425 | Jun 07, 2011, 05:27 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Flynn James E | 10% Owner | Nov 03, 2010 | Sale | $7.55 | 6,300 | 47,565 | 689,900 | Nov 05, 2010, 05:39 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Flynn James E | 10% Owner | Nov 03, 2010 | Sale | $7.55 | 3,612 | 27,271 | 423,901 | Nov 05, 2010, 05:39 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Flynn James E | 10% Owner | Nov 03, 2010 | Sale | $7.55 | 25,830 | 195,017 | 2,902,743 | Nov 05, 2010, 05:39 PM |
RIGL | | RIGEL PHARMACEUTICALS INC | Flynn James E | 10% Owner | Nov 03, 2010 | Sale | $7.55 | 18,235 | 137,674 | 2,050,745 | Nov 05, 2010, 05:39 PM |